Aurantioobtusin 2-O-β-D-glucopyranoside
CAS No. 439086-30-3
Aurantioobtusin 2-O-β-D-glucopyranoside( ——— )
Catalog No. M38244 CAS No. 439086-30-3
Aurantioobtusin 2-O-β-D-glucopyranoside
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAurantioobtusin 2-O-β-D-glucopyranoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionAurantioobtusin 2-O-β-D-glucopyranoside
-
DescriptionAurantioobtusin 2-O-β-D-glucopyranoside
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number439086-30-3
-
Formula Weight———
-
Molecular Formula———
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Gly-Gly-Gly-Oet.HCl|...
Gly-Gly-Gly-Oet.HCl|H-Gly-Gly-Gly-Oet.HCl
-
DPPS
DPPS (12-Dipalmitoyl-sn-glycero-3-PS sodium salt) is an anionic diacyl-phospholipid, a form of phosphatidylserine (PS), which is a negatively charged phospholipid located in the lobules of cell membranes. DPPS are used to make cationic vesicles and liposomes.
-
CGGRGD
CGGRGD is a RGD derivative with cysteine as the n-terminal. CGGRGD was synthesized by solid phase peptide synthesis technology, and amino2-cyanobenzothiazole (2-cyanobenzothiazole) (2-cyanobenzothiazole (CBT) was added on the surface of PCL fiber for ammoniation.
Cart
sales@molnova.com